Symbiotec Pharmalab IPO
Pharmaceutical APIs & Complex Injectables (Specialty Pharma) - Listed on 01 September 2026
Symbiotec Pharmalab IPO listing summary
Symbiotec Pharmalab (Pharmaceutical APIs & Complex Injectables (Specialty Pharma)) closed its IPO window in 2026 and listed on NSE and BSE on 01 September 2026 at an upper band issue price of Rs 988, opening at Rs 988 for a listing gain of 0.0% and closing day one at Rs 1097.7 (+11.1% on closing basis). The IPO was subscribed 75.06x overall - QIB 181.20x, HNI/NII 77.56x, Retail 13.65x. The total issue size was Rs 1,757 Cr (Fresh Issue Rs 150 Cr, OFS Rs 1607 Cr). IPO GMP data, subscription trends across Day 1 - Day 3 and Nifty performance around the listing window are detailed below.
Listing day performance
Subscription breakdown
Final (Day 3) subscription
Number of times each investor category subscribed by close of Day 3.
Day-wise overall subscription
How overall subscription built up across the three-day issue window.
Symbiotec Pharmalab IPO GMP history
Grey market premium (GMP) tracked day-by-day across the IPO window. Absolute GMP is the premium in rupees over the upper issue price; GMP % is that premium as a percent of the issue price.
| Day | GMP (Rs) | GMP % |
|---|---|---|
| Day 1 | Rs 350 | +35.43% |
| Day 2 | Rs 270 | +27.33% |
| Day 3 | Rs 269 | +27.20% |
| Day 4 | Rs 325 | +32.90% |
| Day 5 | Rs 345 | +34.92% |
GMP Prediction vs IPOGyani AI Prediction
Comparison between market-based GMP prediction and IPOGyani's AI-powered listing gain prediction.
Prediction Accuracy: 29.8 pp (Variance observed)
Issue & financials
Market context at listing
How the broader market moved around the Symbiotec Pharmalab IPO window. Helpful for isolating how much of the listing gain came from company fundamentals vs. market tailwind.
Symbiotec Pharmalab IPO - FAQs
What was the listing gain of Symbiotec Pharmalab IPO?
Symbiotec Pharmalab IPO listed at 0.0% versus the upper issue price of Rs 988 on 01 September 2026.
How many times was Symbiotec Pharmalab IPO subscribed?
Symbiotec Pharmalab IPO was subscribed 75.06x overall. QIB portion was subscribed 181.20x, HNI / NII 77.56x and Retail 13.65x.
What was the IPO GMP for Symbiotec Pharmalab?
IPO GMP started at Rs 350 on Day 1 and moved to Rs 345 by the close of the issue window. See the day-by-day GMP table above for the full trajectory.